Alpha Tau to Participate in Sidoti Small-Cap Conference
Tweet
Share
E-mailJERUSALEM, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that management will present at the Sidoti Small-Cap Virtual Conference on Thursday, December 7th, 2023.
| Format: | Presentation and 1-on-1 meetings |
| Date: | December 7th, 2023 |
| Time: | 9:15 AM ET |
| Location: | Virtual |
| Registration: | https://sidoti.zoom.us/webinar/register/WN_VNDWwCEtSeySoAVKVx38YQ |
About Alpha Tau Medical, Ltd.
Founded in 2016, Alpha Tau is an Israeli medical device company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.
Investor Relations Contact:[email protected]
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Sidoti & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
